Connect your AI

Travere Therapeutics, Inc. TVTX Price / sales

Price / sales at other companies

Vertex PharmaceuticalsVRTX

9.3×-1.9×

LQD

Liquidia CorporationLQDA

11.5×-77.4×

BridgeBio PharmaBBIO

24.8×-26.8×

PTC TherapeuticsPTCT

6.8×+4.6×

Catalyst PharmaceuticalCPRX

5.1×-0.4×

Acadia PharmaceuticalsACAD

3.5×+0.7×

Other financials

Income statement

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

Operating cash flow-$40.4M+4.3%

CapEx$140.0K—

Free cash flow-$42.5M+28.1%

Valuation

Market cap$5.13B+72.3%

Profitability

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Calculated from Travere Therapeutics, Inc.’s reported figures.

market cap/total revenue=5.1×

Based on the most recent quarter.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Travere Therapeutics, Inc.'s price / sales?: Travere Therapeutics, Inc. (TVTX) reported price / sales of 5.1× in Q1 2026.
How has Travere Therapeutics, Inc.'s price / sales changed year-over-year?: Travere Therapeutics, Inc.'s price / sales decreased by 12.1% year-over-year, from 5.8× to 5.1×.
What is the long-term trend for Travere Therapeutics, Inc.'s price / sales?: Over 4 years (2020 to 2025), Travere Therapeutics, Inc.'s price / sales has grown at a -2.6% compound annual growth rate (CAGR), from 7.7× to 7×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.